Relationship between rs4349859 and rs116488202 polymorphisms close to MHC-I region and serum urate levels in patients with gout

[1]  R. Sánchez-Sánchez,et al.  The interplay between HLA-B and NLRP3 polymorphisms may be associated with the genetic susceptibility of gout , 2022, Molecular Biology Reports.

[2]  Jan-Gowth Chang,et al.  Genetic contributions to female gout and hyperuricemia using genome-wide association study and polygenic risk score analyses. , 2022, Rheumatology.

[3]  T. Merriman,et al.  A Polynesian-specific copy number variant encompassing the MHC Class I Polypeptide-related Sequence A (MICA) gene associates with gout. , 2022, Human molecular genetics.

[4]  Xiulong Xu,et al.  Uric acid accumulation in DNA-damaged tumor cells induces NKG2D ligand expression and antitumor immunity by activating TGF-β-activated kinase 1 , 2022, Oncoimmunology.

[5]  J. Shang,et al.  Variation of Serum Uric Acid Is Associated With Gut Microbiota in Patients With Diabetes Mellitus , 2022, Frontiers in Cellular and Infection Microbiology.

[6]  R. Benndorf,et al.  The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout—An Update , 2021, International journal of molecular sciences.

[7]  J. Dopazo,et al.  Taxonomic variations in the gut microbiome of gout patients with and without tophi might have a functional impact on urate metabolism , 2021, Molecular Medicine.

[8]  A. Doria,et al.  Autoinflammatory Features in Gouty Arthritis , 2021, Journal of clinical medicine.

[9]  Douglas J. Matthies,et al.  Major Histocompatibility Complex Class I-Related Chain A (MICA) Allelic Variants Associate With Susceptibility and Prognosis of Gastric Cancer , 2021, Frontiers in Immunology.

[10]  K. Bogunia-Kubik,et al.  Shared epitope and polymorphism of MICA and NKG2D encoding genes in Greek and Polish patients with rheumatoid arthritis , 2021, Central-European journal of immunology.

[11]  G. Kahaly,et al.  Type 1 Diabetes and Autoimmune Thyroid Disease—The Genetic Link , 2021, Frontiers in Endocrinology.

[12]  D. Mikhailidis,et al.  Serum uric acid and diabetes: from pathophysiology to cardiovascular disease. , 2021, Current pharmaceutical design.

[13]  K. Node,et al.  Uric acid and cardiovascular disease: A clinical review. , 2020, Journal of cardiology.

[14]  L. Punzi,et al.  One year in review 2020: gout. , 2020, Clinical and experimental rheumatology.

[15]  J. Kunz,et al.  Understanding the Pathogenesis of Spondyloarthritis , 2020, Biomolecules.

[16]  J. Singh,et al.  Gout epidemiology and comorbidities. , 2020, Seminars in arthritis and rheumatism.

[17]  Y. Okada,et al.  Genomic dissection of 43 serum urate-associated loci provides multiple insights into molecular mechanisms of urate control. , 2020, Human molecular genetics.

[18]  Xiaodong Zhou,et al.  MICA*049, not MICA*009, is associated with Behçet’s disease in a Chinese population , 2019, Scientific Reports.

[19]  M. Kanai,et al.  Genome-wide meta-analysis identifies multiple novel loci associated with serum uric acid levels in Japanese individuals , 2019, Communications Biology.

[20]  M. Chou,et al.  The Interaction between Sex and Hyperlipidemia on Gout Risk Is Modulated by HLA-B Polymorphic Variants in Adult Taiwanese , 2019, Genes.

[21]  M. Elshahaly,et al.  Gout: An old disease in new perspective – A review , 2017, Journal of advanced research.

[22]  A. Abou-Elela.  Epidemiology, pathophysiology, and management of uric acid urolithiasis: A narrative review , 2017, Journal of advanced research.

[23]  Shuai Jiang,et al.  Effects of multiple genetic loci on the pathogenesis from serum urate to gout , 2017, Scientific Reports.

[24]  M. Bicalho,et al.  MICA and NKG2D: Is There an Impact on Kidney Transplant Outcome? , 2017, Front. Immunol..

[25]  H. Hmouda,et al.  Drug-induced hyperuricaemia and gout. , 2016, Rheumatology.

[26]  Xiulong Xu,et al.  Xanthine oxidoreductase is required for genotoxic stress-induced NKG2D ligand expression and gemcitabine-mediated antitumor activity , 2016, Oncotarget.

[27]  K. Pavelka,et al.  Novel dysfunctional variant in ABCG2 as a cause of severe tophaceous gout: biochemical, molecular genetics and functional analysis. , 2016, Rheumatology.

[28]  A. Ogdie,et al.  2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative , 2015, Annals of the rheumatic diseases.

[29]  T. Merriman.  An update on the genetic architecture of hyperuricemia and gout , 2015, Arthritis Research & Therapy.

[30]  Y. H. Lee,et al.  Meta-analysis of the association between functional MICA-TM polymorphisms and systemic lupus erythematosus, rheumatoid arthritis and ankylosing spondylitis , 2015, Zeitschrift für Rheumatologie.

[31]  R. Burini,et al.  High plasma uric acid concentration: causes and consequences , 2012, Diabetology & Metabolic Syndrome.

[32]  P. Gattuso,et al.  Major histocompatibility complex class I-related chain A/B (MICA/B) expression in tumor tissue and serum of pancreatic cancer: Role of uric acid accumulation in gemcitabine-induced MICA/B expression , 2011, BMC Cancer.

[33]  Hyon K. Choi,et al.  Genetics of gout , 2010, Current opinion in rheumatology.

[34]  M. Phipps,et al.  MICA polymorphism: biology and importance in immunity and disease. , 2010, Trends in molecular medicine.

[35]  D. Levy,et al.  Genome-wide search for genes affecting serum uric acid levels: the Framingham Heart Study. , 2005, Metabolism: clinical and experimental.

[36]  V. Stenszky,et al.  Clinical and family studies in Hungarian patients with gout , 2004, Rheumatology International.

[37]  J. Glas,et al.  MICA, MICB and C1_4_1 polymorphism in Crohn's disease and ulcerative colitis. , 2001, Tissue antigens.

[38]  M. Hammond,et al.  Gout in black South Africans: a clinical and genetic study. , 1994, Annals of the rheumatic diseases.

[39]  K. Bielska,et al.  HLA antigens in gouty patients. , 1978, Archivum immunologiae et therapiae experimentalis.